EPLBB08 | Analytical treatment interruption (ATI) among African women with early ART initiation with or without VRC01 circulating at HIV acquisition: study design and early observations of viral rebound and control | E-poster | Cure interventions |
EPB258 | Analysis of the impact of COVID-19 pandemic on PrEP uptake in Toronto: a retrospective 18-month single-site chart review | E-poster | Impact of COVID-19 on HIV care |
EPLBA02 | Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T cell correlates of HIV-1 acquisition risk | E-poster | Cellular immunity; T cell vaccines |
EPC454 | Analysis of HIV case finding and continuity on treatment strategies and outcomes before and during the COVID-19 pandemic: The RISE Nigeria experience | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
EPF045 | Analysing the role of stigma and racism in harm reduction policy: a tri-country analysis | E-poster | Availability and access to harm reduction (including OST and NSP) |
EPA056 | An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
EPE428 | An innovative HIV self-testing system during COVID-19 pandemic to reach unscreened MSM: results from an online community program | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
EPE057 | An increase in pediatric ART retention after the HIV test and treat policy implementation. A multi-site longitudinal analysis | E-poster | Implementation science of scaling up HIV treatment |
OAA0202 | An immunological signature for subclinical atherosclerosis in people living with HIV-1 receiving antiretroviral therapy | Oral abstract session with live Q&A | HIV and co-morbidities |
EPC175 | An evaluation of the HIV risk screening and enrollment process in Mexico's pre-exposure prophylaxis demonstration project' the ImPrEP study | E-poster | Demonstration and pilot projects for prevention (including PrEP, PEP, male circumcision) |